Onabotulinum toxin A
Sponsors
Northwestern University, The Hospital of Vestfold, Corfu Headache Clinic, Isabel Moreno Hay, Walter Reed National Military Medical Center
Conditions
Bladder Pain SyndromeChronic PainFaceFemale Sexual DysfunctionForehead RhytidesGlabellar Frown LinesInterstitial CystitisMigraine Disorders
Early Phase 1
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
Active, not recruitingNCT02019004
Start: 2013-11-01End: 2027-12-01Target: 20Updated: 2026-07-01
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
NCT04715048
Start: 2021-01-01End: 2025-06-30Target: 20Updated: 2023-12-14
Phase 1
Phase 2
Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)
CompletedNCT02735499
Start: 2016-03-31End: 2016-10-31Updated: 2018-11-26
Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain
CompletedNCT03848143
Start: 2019-09-11End: 2025-06-30Updated: 2026-07-30
Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
CompletedNCT04401176
Start: 2020-09-15End: 2023-06-01Updated: 2023-10-12
Phase 4
Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine
CompletedNCT03606356
Start: 2015-04-01End: 2018-04-01Updated: 2018-07-30
Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles
CompletedNCT05840445
Start: 2020-06-15End: 2021-01-15Updated: 2023-05-03
A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles
CompletedNCT07072806
Start: 2022-06-14End: 2022-09-07Updated: 2025-07-18